New Kidney Cancer Vaccine Fails at the Last Level

by Tanya Thomas on  July 4, 2008 at 11:15 AM Drug News   - G J E 4
According to a study released on Friday, a new kidney cancer vaccine failed in last-phase of clinical trials to improve the odds of avoiding remission after tumour-removing surgery,.
 New Kidney Cancer Vaccine Fails at the Last Level
New Kidney Cancer Vaccine Fails at the Last Level

A team of researchers led by Christopher Wood of the Anderson Cancer Center in Houston, Texas gave the vaccine, called vitespen, to 409 patients whose cancerous tumours had been removed.

They then compared the relapse and survival rates to a second group that received no additional treatment.

The difference in outcomes was statistically insignificant, reported the study, published in the British journal The Lancet.

A large number of renal cancer patients relapse after surgery, earlier research has shown. When this happens, it is lethal -- there is no cure for metastatic kidney cancer.

The new vaccine was designed to help prevent such remissions.

There were more than 200,000 new cases of kidney cancer worldwide in 2004, and just over 100,000 deaths, according to the International Agency for Research on Cancer.

Renal cell carcinoma is the most common type of kidney cancer in adults, accounting for about 85 percent of all kidney tumours.

The study also showed that a subset of patients with early stages of the disease who had been given vitespin fared marginally better than a control group, but said further trials were needed to verify these results.

In a sharply-worded comment, also published in The Lancet, James Yang of the National Cancer Institute of Bethesda, Maryland chided vaccine manufacturers which "cannot accept the results of randomised trials" that do not meet their expectations.

Selectively highlighting partial findings weakens the credibility of the nascent field of cancer immunotherapy", he said.

Source: AFP

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
A study on Cancer by the International agency for cancer research shows 200.000 new cases of kidney cancer worldwide in the year 2004, and more than 100,000 deaths as per this article. The whole world is hoping and waiting for good remedial result and cure!
guest Saturday, July 5, 2008

You May Also Like